Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Elizabeth Fry

Elizabeth Fry

Contact information

Email
elizabeth.fry@strubi.ox.ac.uk

Research groups

Stuart Group: Structural Virology

Elizabeth Fry

Post Doctoral Research Associate

Recent publications

Author Correction: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

Zhang Y. et al, (2025), NPJ vaccines, 10

An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.

Zhang Y. et al, (2025), NPJ vaccines, 10

Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Sherry L. et al, (2025), NPJ vaccines, 10

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.

Sherry L. et al, (2025), Nature communications, 16

A broadly reactive ultralong bovine antibody that can determine the integrity of foot-and-mouth disease virus capsids.

Clarke JD. et al, (2024), The Journal of general virology, 105